Home/Acurx Pharmaceuticals/Robert J. DeLuccia

RJ

Robert J. DeLuccia

Executive Chairman, Director, Co-Founder

Acurx Pharmaceuticals

Therapeutic Areas

Infectious Disease Gastroenterology

Acurx Pharmaceuticals Pipeline

Drug	Indication	Phase
Ibezapolstat (ACX-362E)	Clostridioides difficile Infection (CDI)	Phase 2b
ACX-375C	Gram-Positive Infections (e.g., MRSA, VRE)	Preclinical

Leadership Team at Acurx Pharmaceuticals

President, Chief Executive Officer, Director, Co-Founder

View full Acurx Pharmaceuticals profile